Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women receiving anthracycline/cyclophosphamide-containing chemotherapy: Meta-analysis of individual patient data examining the effect of age on outcome in two phase III trials

Supportive Care in Cancer

Volumn 21, Issue 2, 2013, Pages 565-573

  Celio, Luigi ^a   Bonizzoni, Erminio ^b   Bajetta, Emilio ^c   Sebastiani, Silvia ^d   Perrone, Tania ^e   Aapro, Matti S ^f  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Istituto di Oncologia   (Italy)

^d HELSINN HEALTHCARE SA   (Switzerland)

^e Italfarmaco SpA   (Italy)

^f CLINIQUE DE GENOLIER   (Switzerland)

Author keywords

AC containing chemotherapy; Breast cancer; CINV; Dexamethasone; Meta analysis; Palonosetron

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; PALONOSETRON;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CLINICAL ASSESSMENT; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DRUG EFFECT; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MULTICENTER STUDY (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; ANTHRACYCLINES; ANTIEMETICS; ANTINEOPLASTIC AGENTS, ALKYLATING; BREAST NEOPLASMS; CLINICAL TRIALS, PHASE III AS TOPIC; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ISOQUINOLINES; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NAUSEA; QUINUCLIDINES; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME; VOMITING;

EID: 84874115358     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1558-9     Document Type: Article

References (20)

1. Aapro M (2005) Optimising antiemetic therapy: what are the problems and how can they be overcome? Curr Med Res Opin 21:885-897. doi: 10.1185/030079905x46313
2. Hesketh PJ (2008) Chemotherapy-induced nausea and vomiting. N Engl J Med 358:2482-2494
3. Roila F, Herrstedt J, Aapro M et al (2010) Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 21(suppl 5):v232-v243. doi: 10.1093/annonc/mdq194
4. Basch E, Prestrud AA, Hesketh PJ et al (2011) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29:4189-4198. doi: 10.1200/JCO.2010.34.4614
5. Celio L, Denaro A, Canova S, Gevorgyan A, Bajetta E (2008) Clinical update on palonosetron in the management of chemotherapy-induced nausea and vomiting. Tumori 94:447-452
6. Saito M, Aogi K, Sekine I et al (2009) Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomized, comparative phase III trial. Lancet Oncol 10:115-124. doi: 10.1016/s1470-2045(08)70313-9
7. Vardy J, Chiew KS, Galica J, Pond GR, Tannock IF (2006) Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br J Cancer 94:1011-1015. doi: 10.1038/sj.bjc.6603048
8. Olver I, Molassiotis A, Aapro M, Herrstedt J, Grunberg S, Morrow G (2011) Antiemetic research: future directions. Support Care Cancer 19(suppl 1):s49-s55. doi: 10.1007/s00520-010-1036-1
9. Aapro M, Fabi A, Nolè F, Medici M, Steger G, Bachmann C, Roncoroni S, Roila F (2010) Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy. Ann Oncol 21:1083-1088. doi: 10.1093/annonc/mdp584
10. Celio L, Frustaci S, Denaro A et al (2011) Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial. Support Care Cancer 19:1217-1225. doi: 10.1007/s00520-010-0941-7
11. Teramukai S, Matsuyama Y, Mizuno S, Sakamoto J (2004) Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect. Jpn J Clin Oncol 34:717-721. doi: 10.1093/jjco/hyh138
12. du Bois A, Vach W, Wechsel U, Holy R, Schaefer W (1996) 5-Hydroxyindoleacetic acid (5-HIAA) and cortisol excretion as predictors of chemotherapy-induced emesis. Br J Cancer 74:1137-1140
13. Hursti TJ, Fredrikson M, Steineck G, Borjeson S, Furst CJ, Peterson C (1993) Endogenous cortisol exerts antiemetic effect similar to that of exogenous corticosteroids. Br J Cancer 68:112-114
14. Wilkinson CW, Petrie EC, Murray SR, Colasurdo EA, Raskind MA, Peskind ER (2001) Human glucocorticoid feedback inhibition is reduced in older individuals: evening study. J Clin Endocrinol Metab 86:545-550. doi: 10.1210/jc.86.2.545
15. American Cancer Society. Breast cancer facts and figures 2009-2010. www.cancer.org/acs/groups/content/@nho/documents/document/f861009final90809pdf. pdf Accessed 26 July 2011.
16. Jakobsen JN, Herrstedt J (2009) Prevention of chemotherapy-induced nausea and vomiting in elderly cancer patients. Crit Rev Oncol Hematol 71:214-221. doi: 10.1016/j.critrevonc.2008.12.006
17. Warr DG, Street JC, Carides AD (2011) Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin-cyclophosphamide-based chemotherapy. Support Care Cancer 19:807-813. doi: 10.1007/s00520-010-0899-5
18. Yap K, Leong C, Chan A (2012) Controlling chemotherapy-induced nausea and vomiting with neurokinin-1 receptor antagonists in patients on AC-based chemotherapy - are we there yet? J Cancer Ther 3:90-102. doi: 10.4236/jct.2012.31012
19. Feyer P, Jordan K (2011) Updated and new trends in antiemetic therapy: the continuing need for novel therapies. Ann Oncol 22:30-38. doi: 10.1093/annonc/mdq600
20. Booth CM, Clemons M, Dranitsaris G, Joy A, Joung S, Callaghan W, Trudeau M, Petrella T (2007) Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study. J Support Oncol 5:374-380